A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NOACs

Search Conditions:
Search Keyword : NOACs
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NOACs
Appearance Frequency: 1458 time(s)
Long forms: 21

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
non-vitamin K antagonist oral anticoagulants
(612 times)
Cardiology
(201 times)
AF (289 times)
VKAs (96 times)
NVAF (66 times)
2013 Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?
novel oral anticoagulants
(601 times)
Cardiology
(154 times)
AF (193 times)
VKAs (104 times)
VTE (72 times)
2012 Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.
non-vitamin K oral anticoagulants
(197 times)
Cardiology
(54 times)
AF (78 times)
VKAs (35 times)
OAC (17 times)
2014 Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
non-vitamin K antagonist OACs
(8 times)
Cardiology
(3 times)
AF (6 times)
OACs (5 times)
OAC (3 times)
2015 Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
new oral anticoagulant drugs
(7 times)
Medicine
(2 times)
AF (2 times)
VKA (2 times)
AC (1 time)
2014 [Pulmonary embolism due to interaction between rivaroxaban and carbamazepine].
novel anticoagulants
(6 times)
Vascular Diseases
(3 times)
AF (2 times)
VTE (2 times)
ACS (1 time)
2013 Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation.
novel OACs
(4 times)
Cardiology
(3 times)
OAC (3 times)
ACS (1 time)
AEs (1 time)
2013 The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation.
new OACs
(3 times)
Neurology
(1 time)
OAC (2 times)
AF (1 time)
FXa (1 time)
2013 Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
New-generation oral anticoagulants
(3 times)
Pharmacology
(1 time)
GI (1 time)
MPV (1 time)
PDW (1 time)
2015 Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management.
10  non-VKA OACs
(3 times)
Internal Medicine
(2 times)
AF (3 times)
OAC (3 times)
VKAs (2 times)
2015 Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation.
11  new orally active anticoagulants
(2 times)
Anesthesia
(1 time)
AF (1 time)
DVT (1 time)
PE (1 time)
2013 New orally active anticoagulants in critical care and anesthesia practice: the good, the bad and the ugly.
12  non-vitamin K OACs
(2 times)
Internal Medicine
(1 time)
ACS (1 time)
AF (1 time)
DAPT (1 time)
2019 Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances.
13  novel direct OACs
(2 times)
Heart Diseases
(1 time)
AF (1 time)
HF (1 time)
ICH (1 time)
2014 Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view.
14  (VKAs)-non-VKA oral anticoagulants
(1 time)
Science
(1 time)
NMA (1 time)
RCTs (1 time)
RWD (1 time)
2019 Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.
15  antagonist oral anticoagulants
(1 time)
Vascular Diseases
(1 time)
MMAS (1 time)
PDT (1 time)
2019 NOAC Adherence of Patients with Atrial Fibrillation in the Real World: Dosing Frequency Matters?
16  new US Food and Drug Administration-approved oral anticoagulants
(1 time)
Medicine
(1 time)
RCTs (1 time)
RR (1 time)
2014 Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients.
17  non-VKA oral ACs
(1 time)
Cardiology
(1 time)
AC (1 time)
AF (1 time)
AP (1 time)
2016 Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
18  NOS-containing amacrine cells
(1 time)
Neurology
(1 time)
GCs (1 time)
IR (1 time)
NO (1 time)
2010 Light responses and morphology of bNOS-immunoreactive neurons in the mouse retina.
19  Novel anticoagulations
(1 time)
Vascular Diseases
(1 time)
VKAs (1 time)
2017 Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed.
20  novel orally administered anticoagulant agents
(1 time)
Female Urogenital Diseases
(1 time)
--- 2016 Managing novel orally administered anticoagulants in patients undergoing urogynaecological surgery.
21  number of other oral medications
(1 time)
Neoplasms
(1 time)
BNHO (1 time)
DGP (1 time)
LMWH (1 time)
2016 Practice Patterns for Prophylaxis and Treatment of Venous Thromboembolism in German Cancer Patients.